Compounds > 1,1-bis(4-hydroxyphenyl)-2-phenylbut-1-ene

Page last updated: 2024-08-24

1,1-bis(4-hydroxyphenyl)-2-phenylbut-1-ene and Breast Neoplasms

1,1-bis(4-hydroxyphenyl)-2-phenylbut-1-ene has been researched along with Breast Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Boubeker, L; Hillard, E; Jaouen, G; Pigeon, P; Spera, D; Top, S; Vessières, A	1
Curpan, RF; Jordan, VC; Lewis-Wambi, JS; Maximov, PY; Myers, CB	1
Carlson, KE; Katzenellenbogen, BS; Katzenellenbogen, JA; Kieser, KJ; Kim, DW	1
Almeida, CF; Amaral, C; Augusto, TV; Correia-da-Silva, G; Fernandes, PA; Oliveira, A; Ramos, MJ; Teixeira, N	1
Jordan, VC; Obiorah, IE	1

Other Studies

5 other study(ies) available for 1,1-bis(4-hydroxyphenyl)-2-phenylbut-1-ene and Breast Neoplasms

Article	Year
Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro. Journal of medicinal chemistry, 2005, Jun-16, Volume: 48, Issue:12 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Ferrous Compounds; Humans; In Vitro Techniques; Metallocenes; Neoplasms, Hormone-Dependent; Organometallic Compounds; Phenols; Structure-Activity Relationship; Uterus	2005
Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen. Journal of medicinal chemistry, 2010, Apr-22, Volume: 53, Issue:8 Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Estrogen Antagonists; Estrogens, Non-Steroidal; Ethylenes; Female; Humans; Models, Molecular; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Tamoxifen	2010
Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs). Journal of medicinal chemistry, 2010, Apr-22, Volume: 53, Issue:8 Topics: Acrylates; Adaptor Proteins, Signal Transducing; Binding, Competitive; Breast Neoplasms; Bridged Bicyclo Compounds; Carbonic Anhydrases; Cell Line, Tumor; Cyclofenil; Down-Regulation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Ligands; Microfilament Proteins; Neuropeptides; Nuclear Proteins; Radioligand Assay; Receptors, Progesterone; RNA, Messenger; Structure-Activity Relationship; Transcription, Genetic; Trefoil Factor-1; Tumor Suppressor Proteins	2010
Discovery of a multi-target compound for estrogen receptor-positive (ER Biochimie, 2021, Volume: 181 Topics: Antineoplastic Agents; Aromatase; Breast Neoplasms; Drug Screening Assays, Antitumor; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; MCF-7 Cells; Neoplasm Proteins; Signal Transduction; Stilbenes	2021
Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol. British journal of pharmacology, 2014, Volume: 171, Issue:17 Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured	2014